Tumor Skin
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Use of Talimogene Laherparepvec and BRAF/MEK Inhibitor for Advanced Nodal BRAF Mutant Melanoma (NCT03972046) | TriHealth Inc. | 2019-06-24 |
Track Tumor Skin automatically
Every clearance here is in the API, with alerts when new ones post.